Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B.
Kindler HL, Herndon JE, Zhang C, Green MR. Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B. Lung Cancer. 2005 Jun; 48(3):423-8.